Attention deficit hyperactivity disorder (ADHD) is commonly co–occurring with other psychiatric disorders including substance use disorders. Stimulants have proven to be the pharmacological treatment of choice of ADHD along the life span. Contrary to media hype which compared the addictive potential of methylphenidate (MPD) to cocaine, only a handful of case studies on the abuse of prescription MPD by ADHD patients have been published. This case study centers on the treatment management and aftercare implications of an adult ADHD patient who abused 700 mg of prescribed MPD intranasally during a 3–day binge.
BiedermanJ, MickE and FaraoneSV. 2000. Age–dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. Am J Psychiatry, 157: 816–818.
2.
MannuzzaS, KleinRG, BesslerA, MalloyP and LaPadulaM. 1998. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry, 155: 493–498.
3.
BiedermanJ, NewcornJ and SprichS. 1991. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry, 148: 564–577.
4.
BiedermanJ, WilensT, MickE, FaraoneSV, WeberW, CurtisS, ThornellA, PfisterK, JettonJG and SorianoJ. 1997. ADHD a risk factor for psychoactive substance use disorders? Findings from a four–year prospective follow–up study. Am Acad Child Adolesc Psychiatry, 36: 21–29.
5.
KhantzianFJ, GawinF and KleberHD. 1984. Methylphenidate treatment of cocaine dependence. J Subst Abuse Treatment, 1: 107–112.
6.
CastanedaR. 1994. Empirical assessment of the self–medication hypothesis among dually diagnosed inpatients. Comp Psychiatry, 35: 180–184.
7.
CastanedaR, LevyR, HardyM and TrujilloM. 2000. Long–acting stimulants for the treatment of attention deficit disorder in cocaine dependent adults. Psych Services, 51: 169–171.
8.
KaminerY. 1992. Clinical implications of the relationship between attention deficit hyperactivity disorder and psychoactive substance use disorders. Am J Addictions, 1: 257–264.
9.
VolkowND, DingYS and FowlerJS. 1995. Is methylphenidate like cocaine?. Archives Gen Psychiatry, 52: 456–463.
10.
VolkowND, WangGJ, FowlerJS, HitzemannR, AngristB, GatleySJ, LoganJ, DingYS and PappasN. 1999. Association of methylphenidate–induced craving with changes in right striato–orbitofrontal metabolism in cocaine abusers: Implications in addiction. Am J Psychiatry, 156: 19–26.
11.
VolkowND, ChangL, WangGJ, FowlerJS, FranceschiD, SedlerM, GatleySJ, HitzemannR, DingYS, WongC and LoganJ. 2001. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry, 158: 383–389.
12.
Drug Enforcement Administration. Methylphenidate Review 1995, Washington, DC: Drug Enforcement Administration, Office of Diversion Control Drug and Chemical Evaluation Section.
13.
SaferDJ, ZitoJM and FineEM. 1996. Increased methylphenidate usage for attention deficit disorder in the 1990's. Pediatrics, 98: 1084–1088.
14.
LianaME and CrismonML. 1999. Methylphenidate: Increased abuse or appropriate use?. J Am Pharm Assoc, 39: 526–530.
15.
WaidLR, JohnsonDE and AntonRF. 1998. “Attention–deficit hyperactivity disorder and substance abuse”. In Dual Diagnosis and Treatment, Edited by: KranzlerHR and RounsavilleBJ. 393–425. New York: Marcel Dekker.
16.
KaminerY. 2001. “Psychopharmacological therapy”. In Innovations in Adolescent Substance Abuse Interventions, Edited by: WagnerEF and WaldronHB. New York: Elsevier.
